EU Cites ‘Constructive’ Talks With Gilead Over Virus Drug (1)

European Union officials held talks with Gilead Sciences Inc. executives on Monday in a bid to hammer out a deal to secure its antiviral drug remdesivir to combat the coronavirus.

Health Commissioner Stella Kyriakides spoke with Gilead about purchasing the drug on behalf of 16 EU countries, including Germany, Belgium, the Netherlands, Austria and Denmark, a person familiar with the matter said on the condition of anonymity before the exchange. Kyriakides was also expected to inquire about Gilead’s production capacity and timeline for delivery.

“Constructive” talks with Gilead continued in the afternoon “regarding the production capacity and access to remdesivir ...